May's top stories: Funders and NGOs agreed on new standards, Actinogen's Xanamem in Phase II

Medical research funders and international NGOs agreed to implement the new WHO standards for clinical trials, and Actinogen Medical began patient enrolment and dosing in the Phase II XanADu clinical trial of Xanamem for the treatment of Alzheimer ’s …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news